Cost-Utility and Cost-Effectiveness Analyses of Face-to-Face Versus Telephone-Based Nonpharmacologic Multidisciplinary Treatments for Patients With Generalized Osteoarthritis

被引:14
|
作者
Cuperus, Nienke [1 ]
van den Hout, Wilbert B. [2 ]
Hoogeboom, Thomas J. [3 ]
van den Hoogen, Frank H. J. [1 ]
Vlieland, Thea P. M. Vliet [2 ]
van den Ende, Cornelia H. M. [1 ]
机构
[1] Sint Maartensklin, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Maastricht Univ, NL-6200 MD Maastricht, Netherlands
关键词
KNEE OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; HEALTH; CARE; MANAGEMENT; HIP; RECOMMENDATIONS; TRIAL; RESPONSIVENESS; ECONOMICS;
D O I
10.1002/acr.22709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate, from a societal perspective, the cost utility and cost effectiveness of a nonpharmacologic face-to-face treatment program compared with a telephone-based treatment program for patients with generalized osteoarthritis (GOA). Methods. An economic evaluation was carried out alongside a randomized clinical trial involving 147 patients with GOA. Program costs were estimated from time registrations. One-year medical and nonmedical costs were estimated using cost questionnaires. Quality-adjusted life years (QALYs) were estimated using the EuroQol (EQ) classification system, EQ rating scale, and the Short Form 6D (SF-6D). Daily function was measured using the Health Assessment Questionnaire (HAQ) disability index (DI). Cost and QALY/effect differences were analyzed using multilevel regression analysis and cost-effectiveness acceptability curves. Results. Medical costs of the face-to-face treatment and telephone-based treatment were estimated at (sic)387 and (sic)252, respectively. The difference in total societal costs was nonsignificantly in favor of the face-to-face program (difference (sic)708; 95% confidence interval [95% CI] -(sic)5,058, (sic)3,642). QALYs were similar for both groups according to the EQ, but were significantly in favor of the face-to-face group, according to the SF-6D (difference 0.022 [95% CI 0.000, 0.045]). Daily function was similar according to the HAQ DI. Since both societal costs and QALYs/effects were in favor of the face-to-face program, the economic assessment favored this program, regardless of society's willingness to pay. There was a 65-90% chance that the face-to-face program had better cost utility and a 60-70% chance of being cost effective. Conclusion. This economic evaluation from a societal perspective showed that a nonpharmacologic, face-to-face treatment program for patients with GOA was likely to be cost effective, relative to a telephone-based program.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 44 条
  • [41] Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years' follow-up
    Tiberg, Iren
    Lindgren, Bjorn
    Carlsson, Annelie
    Hallstrom, Inger
    BMC PEDIATRICS, 2016, 16
  • [42] 10-YEAR COST-EFFECTIVENESS ANALYSES OF RESPONSE-BASED USE OF FREMANEZUMAB AS PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE FOR PATIENTS WITH INADEQUATE RESPONSE TO PRIOR PREVENTIVE TREATMENTS
    Smolen, L.
    Thompson, S.
    Klein, T.
    Cohen, J.
    Gandhi, S. K.
    VALUE IN HEALTH, 2019, 22 : S743 - S743
  • [43] Effectiveness and cost-effectiveness of telephone-based support versus usual care for treatment of pressure ulcers in people with spinal cord injury in low-income and middle-income countries: study protocol for a 12-week randomised controlled trial
    Arora, Mohit
    Harvey, Lisa Anne
    Hayes, Alison Joy
    Chhabra, Harvinder Singh
    Glinsky, Joanne Valentina
    Cameron, Ian Douglas
    Lavrencic, Lucija
    Arumugam, Narkeesh
    Hossain, Sohrab
    Bedi, Parneet Kaur
    BMJ OPEN, 2015, 5 (07):
  • [44] Cost-effectiveness and cost-utility analyses comparing two alternative forms of high-molecular-weight hyaluronan, Bio-HA (Euflexxa™) and CL-HA (Synvisc®), for the treatment of pain of osteoarthritis of the knee using data from a double-blind randomized clinical trial.
    Lin, Swu-jane
    Kolsun, Kathleen
    Hatoum, Hind T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S104 - S104